Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Bottoms Up: Improving Proteomic Sample Preparation with Recombinant Asp-N and Multi-Enzyme Workflows

Tryptic digestion often leaves gaps in protein sequences. In this webinar Dr. Hosfield  describes the advantages of using a new recombinant Asp-N protease to fill in the gaps. 

Summary

Bottom-up mass spectrometry workflows typically use trypsin to digest proteins into peptides suitable for LC-MS/MS analysis. While trypsin is an excellent protease, alternative proteases are useful for numerous applications including increasing protein sequence coverage and identifying post-translational modifications.

In this webinar Dr. Hosfield describes the features of a new recombinant Asp-N protease (rAsp-N). rAsp-N displays both high cleavage efficiency and a strong preference for cleavage N-terminal to aspartic acid. He will explain how this enzyme can be effectively used to digest a variety of sample types, including complex protein mixtures and therapeutic molecules such as monoclonal antibodies.

In addition, he describes how a multi-enzyme approach can be successfully employed to achieve 100% sequence coverage of an IgG from a single injection. Combining peptides derived from digestion with orthogonal proteases prior to LC-MS/MS analysis could be a general strategy to ensure high sequence coverage while simultaneously reducing demand on instrument time.


Speaker

chris-hosfield-125x124

Chris Hosfield, PhD
Senior Research Scientist
Promega Corporation

Chris Hosfield is a Senior Research Scientist in the Protein Analysis group at Promega. He has lead the development of tools for proteomics and antibody characterization, including PNGase F and IdeS and recombinant Asp-N proteases.

Chris has broad expertise working with proteolytic enzymes and preparing protein samples for analysis by mass spectrometry. Prior to joining Promega, Chris held senior scientist positions at several biotechnology companies where he applied proteomic methods to the discovery and development of both small molecules and biotherapeutics. He received his Ph.D. in biochemistry from Queen’s University.

We love to talk science.

Sign up to receive monthly invitations to our webinars.

Sign Up